Although in validation set, high LSC17 score also predicted inferior outcomes but did not reach statistical significance (OS high versus low: 48.9% ± 9.3% versus 57.0% ± 5.4%, HR [95% CI], 1.33 [0.73-2.42], P = 0.348; EFS high versus low: 21.5% ± 7.7% versus 37.7% ± 5.1%, HR [95% CI], 1.41 [0.87-2.30], P = 0.164; Suppl.
← all excerpts
Integration of Transcriptomic Features to Improve Prognosis Prediction of Pediatric Acute Myeloid Leukemia With KMT2A Rearrangement.
1
0.3480
0.3480